• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OncoGenex Pharmaceutical Inc

+ Add to Watchlist

SP4A:GR

7.285 EUR 0.101 1.41%

As of 02:02:29 ET on 04/17/2014.

Snapshot for OncoGenex Pharmaceutical Inc (SP4A)

Open: 7.492 Day's Range: 7.285 - 7.492 Volume: 140
Previous Close: 7.184 52wk Range: 4.853 - 10.121 1-Yr Rtn: -7.03%

Stock Chart for SP4A

No chart data available.
  • SP4A:GR 7.285
  • 1D
  • 1M
  • 1Y
7.184
Interactive SP4A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SP4A

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.5620
Est. PEG Ratio -
Market Cap (M EUR) 107.23
Shares Outstanding (M) 14.72
30 Day Average Volume 38
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SP4A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SP4A

OncoGenex Pharmaceutical Inc. is a biopharmaceutical company that develops and commercializes new cancer therapies that address treatment resistance in cancer patients.

Scott CormackPresident/CEOCindy A JacobsExec VP/Chief Medical Ofcr
More Company Profile & Key Executives for SP4A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil